The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health

by Robert F. Kennedy Jr.

July 2014, Lance Gordon, the BMGF’s director for Neglected Infectious Diseases in its Global Health Program, released news that the Sanofi Pasteur experimental dengue vaccine that Gates and Dr. Fauci funded was showing positive clinical results. Amidst his sunny forecast, Gordon made an ominous allusion that would have sounded DEFCON 1 to anyone decoding its implication. NIAID’s clinical trials in Brazil, he acknowledged, showed signals of “pathogenic priming.” That foreboding phrase describes an enhanced immune response that can trigger system-wide inflammation and death when the vaccinated individual is reexposed to the wild virus. Infectious disease experts and health regulators had recognized the deadly potential of pathogenic priming since the 1980s, when one study showed that “more severe responses were found to be 15–80 times more likely in secondary dengue infections than in primary infections.”

Pathogenic priming example from dengue fever vaccine